TrialAdvances in therapy2025

Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration.

Victoria Navarro-Compán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.